Testing Counseling Styles to Motivate Smokers to Quit
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01188018|
Recruitment Status : Completed
First Posted : August 25, 2010
Last Update Posted : July 4, 2012
|Condition or disease||Intervention/treatment||Phase|
|Smoking Tobacco Use Nicotine Dependence||Behavioral: Brief Advice (BA) Behavioral: Motivational Interviewing (MI) Behavioral: Health Education (HE)||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||255 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Can Motivational Interviewing be Effective for Smoking Cessation?|
|Study Start Date :||October 2010|
|Actual Primary Completion Date :||June 2012|
|Actual Study Completion Date :||June 2012|
|Active Comparator: Brief Advice||
Behavioral: Brief Advice (BA)
Participants in this arm will receive a single session of brief advice. A counselor will briefly discuss the risks associated with smoking.
|Experimental: Motivational Interviewing||
Behavioral: Motivational Interviewing (MI)
Subjects will receive 4 counseling sessions (over 18 weeks) in which their thoughts about their smoking will be discussed. Two of these counseling sessions will be performed in person (weeks 0 and 12) and the remaining two will be over the phone(weeks 6 and 18).
|Active Comparator: Health Education||
Behavioral: Health Education (HE)
Subjects will receive 4 counseling sessions (over 18 weeks)in which they will receive educational information about the risks of smoking and the benefits of quitting. Two of these counseling sessions will be performed in person (weeks 0 and 12) and the remaining two will be over the phone (weeks 6 and 18).
- Quit Attempt(s) [ Time Frame: Any time within 26 weeks ]
- Smoking Cessation [ Time Frame: 7 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01188018
|United States, Missouri|
|University of Missouri-Kansas City|
|Kansas City, Missouri, United States, 64110|
|Principal Investigator:||Delwyn Catley, Ph.D.||University of Missouri, Kansas City|